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Surgical procedures and tissue processing
The animals were weighed before surgery. Surgery was performed under inhalation anesthesia comprising a mixture of oxygen:air (1:1 volume ratio, 2 L/min) and 2-4% isoflurane (Forene, Abbott Laboratories, Chicago, IL, USA). Animals received analgesia pre-operatively by subcutaneous administration of 250 µg/kg buprenorphine (Temgesic, Schering-Plough, Kenilworth, NJ, USA). Body temperature was maintained at 37.0 ± 0.2 °C. A midline laparotomy was performed and the common bile duct was mobilized.
In animals undergoing BDL, the common bile duct was ligated proximally and distally relative to the liver, and the lumen was disconnected in between. In animals undergoing sham surgery, the bile duct was manipulated but not ligated and not disconnected. The abdomen was closed with dual layer sutures.
After 7 days the animals were weighed, anesthetized as described, and euthanized by exsanguination from the vena cava. Blood samples were collected in heparin and EDTA. Liver tissue was snap-frozen in liquid nitrogen and stored at -80 °C for subsequent RNA extraction and HPLC (left lateral and median lobe), and MPO activity, TNF-alpha, and IL-6 measurements (right lateral and median lobe). Samples were also fixed in 10% buffered formalin for histological analysis. A sample from the caudal lobe was weighed, desiccated at 37° C for 4 weeks, and weighed again to determine hepatic water content. Intergroup differences in hepatic water content, calculated by [1 -(dry weight/wet weight)] × 100%, were used as a measure of edema.
Measurement of bile salt composition
Individual bile salt/acid species were separated and quantified by reverse-phase HPLC [1, 2] We achieve good separation of the 17 relevant bile salt species present in rodents using this protocol, as demonstrated by a chromatogram (Supplementary Fig. S1 ). Total bile salt concentrations quantified using HPLC refer to the cumulative of all bile salts/acids, which were consistent with results from an enzyme cycling assay ( Supplementary Fig. S4 ). The mean TβMCA/TCA ratio was calculated by averaging ratios from individual animals.
CYP7A1 regulation assay
HepG2-NTCP cells were cultured at 37 °C in humidified air with 5% CO 2 in Dulbecco's Modified Eagle's Medium (Lonza) supplemented with 10% fetal calf serum (Bodinco), 5 µg/mL insulin (Sigma), 50 µmol/L hydrocortisone hemisuccinate (Sigma), 100 IU/mL penicillin (Lonza), 0.1 mg/mL streptomycin (Lonza), and 2 mmol/L L-glutamine (Lonza). Cells were seeded in 24-well plates. When ~80% confluence was reached, cells were washed with PBS once and medium was changed to serum-free medium supplemented with 1% free fatty acid-free bovine serum albumin (Sigma) with or without addition of bile salts. Twenty-four hours after treatment, RNA was extracted using the RNeasy Mini Kit according to the manufacturer's instructions (Qiagen).
Messenger RNA levels were quantified as described in the main article. Supplementary Fig. S4 . The hepatic total antioxidant capacity is similar in the liver of sham control rats, rats with steatosis, cholestasis, and combined steatosis and cholestasis. A total antioxidant capacity assay (Sigma) was performed as described previously [3] . There were no statistically significant differences detected between the 4 groups (p = 0.42).
Values represent means ± SD for n = 5-6 samples. NAFLD activity scores demonstrate that none of the animals met the histological criteria for NASH diagnosis, which requires a total score ≥ 5. The validated scoring system as described by Kleiner et al. [4] was applied.
Scores are shown as median (range) for n = 5-6 animals per group. Sequences were designed using genomic and cDNA data obtained from GenBank (NCBI). Human CYP7A1 and SHP primers were from Qiagen (QuantiTect Primer Assay). Sequences that were not available from the manufacturer are designated as N.A.
